Cruess WV, and Alsberg CL, The bitter glucoside of the olive. J. Amer. Chem. Soc. 1934; 56:2115-7.

Samuelsson G, The blood pressure lowering factor in leaves of Olea Europaea. Farmacevtisk Revy, 1951; 15: 229-39

Veer WLC et al, A compound isolated from olea europaea. Recueil, 1957; 76: 839-40

Panizzi L et al, The constitution of oleuropein, a bitter glucoside of the olive with hypotensive action. Gazz. Chim. Ital; 1960; 90:1449-85.

Renis HE, In vitro antiviral activity of calcium elenolate. Antimicrob. Agents Chemother., 1970; 167-72.

Elliott GA et al, Preliminary studies with calcium elenolate, an antiviral agent. Antimicrob. Agents Chemother., 1970; 173-76.

Soret MG, Antiviral activity of calcium elenolate on parainfluenza infection of hamsters. Antimicrob. Agents Chemother., 1970; 160-66.

Petkov V and Manolov P, Pharmacological analysis of the iridoid oleuropein. Drug Res., 1972; 22(9); 1476-86.

Juven B et al, Studies on the mechanism of the antimicrobial action of oleuropein. J. Appl. Bact., 1972; 35:559-67.

Hirschman SZ, Inactivation of DNA polymerases of Murine Leukaemia viruses by calcium elenolate. Nature New Biology, 1972; 238:277-79.

Heinze JE et al, Specificity of the antiviral agent calcium elenolate. Antimicrob. Agents Chemother., 1975: 8(4), 421-25.

Kubo I et al, A mutichemical defense mechanism of bitter olive olea europaea (Oleaceae) -- Is oleuropein a phytoalexin precursor? J. Chem. Ecol 1985; 11(2):251-63.

Gariboldi P et al, Secoiridoids from olea europaea, Phytochem., 1986; 25(4) 865-69.

Zarzuelo A et al, Vasodilator effect of olive leaf, Planta Med., 1991; 57 (5), 417-9.

Department of Pharmacology and Toxicology, Society of Pharmaceutical Industries of Tunis, Hypotension, hypoglycemia and hypouricemia recorded after repeated administration of aqueous leaf extract of Olea europaea, Belgian Pharmacology Journal, March-April 1994; 49(2), 101-8.

Visioli F and Galli C, Oleuropein protects low density liproprotein from oxidation, Life Sciences, 1994; 55(24), 1965-71.